{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:47:06Z","timestamp":1758631626151},"reference-count":13,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2003,4]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> The haemostatic activity of von Willebrand Factor (VWF) is dependent on VWF multimer stability. Fragments, arising from the proteolytic cleavage of the multimers by VWF\u2010cleaving protease, are ineffective in initiating platelet aggregation. We designed a simple method to determine the protease activity, which was expressed as the reduction in the level of ristocetin\u2010induced platelet aggregation between the inactive enzyme and the enzyme when activated by the addition of calcium. Samples from senior women (<jats:italic>n<\/jats:italic>\u2003=\u200314) with chronic coronary heart disease (CHD), age\u2010matched control subjects (<jats:italic>n<\/jats:italic>\u2003=\u200315) and young healthy individuals (<jats:italic>n<\/jats:italic>\u2003=\u200313), as well as patients with either thrombotic thrombocytopenic purpura (TTP) (<jats:italic>n<\/jats:italic>\u2003=\u20032) or von Willebrand disease type 2A (VWD\u20102A) (<jats:italic>n<\/jats:italic>\u2003=\u20032), were examined. The lower protease activity observed in the CHD group, compared with the control subjects, indicated that the increased levels of VWF found in CHD relate to impaired enzyme function. The assessment of TTP patients reconfirmed the reduced protease activity previously observed in this disorder. In VWD\u20102A, normal enzyme function was observed, suggesting that there is an increased sensitivity of the mutated VWF protein to the protease, rather than an increase in the activity or quantity of the enzyme involved in pathogenesis. In summary, the present simplified method efficiently determines VWF protease activity and is suitable for use in laboratories where platelet aggregation analyses can be performed.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2003.04257.x","type":"journal-article","created":{"date-parts":[[2004,12,21]],"date-time":"2004-12-21T06:57:10Z","timestamp":1103612230000},"page":"123-129","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Decreased levels of von Willebrand factor\u2010cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura: study of a simplified method for assaying the enzyme activity based on ristocetin\u2010induced platelet aggregation"],"prefix":"10.1111","volume":"121","author":[{"given":"Gina","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margareta","family":"Blomb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Schenck\u2010Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,4]]},"reference":[{"key":"e_1_2_21_2_1","doi-asserted-by":"crossref","first-page":"184\u2013185","DOI":"10.1055\/s-0037-1612926","article-title":"A rapid assay for the VWF protease","volume":"85","author":"Aronson D.L.","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_21_3_1","first-page":"941\u2013945","article-title":"Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia","volume":"84","author":"Deng L.","year":"1994","journal-title":"Obstetrics and Gynecology"},{"key":"e_1_2_21_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050184"},{"key":"e_1_2_21_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392202"},{"key":"e_1_2_21_6_1","doi-asserted-by":"crossref","first-page":"1386\u20131389","DOI":"10.1055\/s-0037-1614780","article-title":"Assay of von Willebrand factor (vWF)\u2010cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)","volume":"82","author":"Gerritsen H.E.","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_21_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.55.1.58"},{"key":"e_1_2_21_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(01)00320-6"},{"key":"e_1_2_21_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.66.5.351"},{"key":"e_1_2_21_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.26"},{"key":"e_1_2_21_11_1","first-page":"1456\u20131462","article-title":"von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura","volume":"78","author":"Karpman D.S.","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_21_12_1","doi-asserted-by":"crossref","first-page":"4223\u20134234","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai H.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_21_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392203"},{"key":"e_1_2_21_14_1","first-page":"1002\u20131007","article-title":"von Willebrand factor (VWF) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the VWF propeptide (VWF:AgII)","volume":"80","author":"Vischer U.M.","year":"1998","journal-title":"Thrombosis and Haemostasis"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04257.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04257.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2003.04257.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:22:43Z","timestamp":1697404963000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2003.04257.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["10.1046\/j.1365-2141.2003.04257.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04257.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]},"assertion":[{"value":"2003-04-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}